The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

Hepatology - Tập 52 Số 3 - Trang 894-903 - 2010
Yaron Rotman1,2, Christopher Koh1,2, Joseph M. Zmuda3, David E. Kleiner4, Tiebing Liang1,5
1Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases,National Institutes of Health,Bethesda,MD
2these authors contributed equally to this work
3Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
4Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD.
5fax: 301-402-0491

Tóm tắt

Từ khóa


Tài liệu tham khảo

Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, HEPATOLOGY, 40, 1387, 10.1002/hep.20466

Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014

Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, HEPATOLOGY, 37, 1202, 10.1053/jhep.2003.50193

Sanyal, 2005, Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease, Nat Clin Pract Gastroenterol Hepatol, 2, 46, 10.1038/ncpgasthep0084

Browning, 2004, Ethnic differences in the prevalence of cryptogenic cirrhosis, Am J Gastroenterol, 99, 292, 10.1111/j.1572-0241.2004.04059.x

Struben, 2000, Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds, Am J Med, 108, 9, 10.1016/S0002-9343(99)00315-0

Willner, 2001, Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease, Am J Gastroenterol, 96, 2957, 10.1111/j.1572-0241.2001.04667.x

Hindorff LA Junkins HA Mehta JP Manolio TA www.genome.gov/gwastudies 2010

Romeo, 2008, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nat Genet, 40, 1461, 10.1038/ng.257

Yuan, 2008, Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes, Am J Hum Genet, 83, 520, 10.1016/j.ajhg.2008.09.012

Kantartzis, 2009, Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene, Diabetes, 58, 2616, 10.2337/db09-0279

Kotronen, 2009, A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans, Diabetologia, 52, 1056, 10.1007/s00125-009-1285-z

Kollerits, 2010, A common variant in the adiponutrin gene influences liver enzyme levels, J Med Genet, 47, 116, 10.1136/jmg.2009.066597

Romeo, 2010, Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent, Int J Obes (Lond), 34, 190, 10.1038/ijo.2009.216

Chalasani, 2009, Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design, Contemp Clin Trials, 30, 88, 10.1016/j.cct.2008.09.003

Lavine, 2010, Treatment of nonalcoholic fatty liver disease in children: TONIC trial design, Contemp Clin Trials, 31, 62, 10.1016/j.cct.2009.09.001

Promrat, 2004, A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis, HEPATOLOGY, 39, 188, 10.1002/hep.20012

Loomba, 2009, Clinical trial: pilot study of metformin for the treatment of nonalcoholic steatohepatitis, Aliment Pharmacol Ther, 29, 172, 10.1111/j.1365-2036.2008.03869.x

Brunt, 2009, Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network, HEPATOLOGY, 49, 809, 10.1002/hep.22724

Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, HEPATOLOGY, 41, 1313, 10.1002/hep.20701

Glynn, 1995, Determinants of bone mineral density in older men, J Bone Miner Res, 10, 1769, 10.1002/jbmr.5650101121

WHO Multicentre Growth Reference Study Group, 2006, The WHO Child Growth Standards: Length/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height, and Body Mass Index-for-Age: Methods and Development

Minelli, 2005, The choice of a genetic model in the meta-analysis of molecular association studies, Int J Epidemiol, 34, 1319, 10.1093/ije/dyi169

Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc Series B Stat Methodol, 57, 289

He, 2010, A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis, J Biol Chem, 285, 6706, 10.1074/jbc.M109.064501

Yeh, 2007, Pathology of nonalcoholic fatty liver disease, Am J Clin Pathol, 128, 837, 10.1309/RTPM1PY6YGBL2G2R

Schwimmer, 2005, Histopathology of pediatric nonalcoholic fatty liver disease, HEPATOLOGY, 42, 641, 10.1002/hep.20842

Sookoian, 2009, A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity, J Lipid Res, 50, 2111, 10.1194/jlr.P900013-JLR200

Loomba, 2009, Advances in pediatric nonalcoholic fatty liver disease, HEPATOLOGY, 50, 1282, 10.1002/hep.23119

Mohanty, 2009, Influence of ethnicity on histological differences in non-alcoholic fatty liver disease, J Hepatol, 50, 797, 10.1016/j.jhep.2008.11.017

Baulande, 2001, Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage, J Biol Chem, 276, 33336, 10.1074/jbc.M105193200

Liu, 2004, Adiponutrin: A new gene regulated by energy balance in human adipose tissue, J Clin Endocrinol Metab, 89, 2684, 10.1210/jc.2003-031978

Polson, 2004, Macronutrient composition of the diet differentially affects leptin and adiponutrin mRNA expression in response to meal feeding, J Nutr Biochem, 15, 242, 10.1016/j.jnutbio.2003.11.009

Faraj, 2006, Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: relation to adiponutrin, J Endocrinol, 191, 427, 10.1677/joe.1.06659

Moldes, 2006, Adiponutrin gene is regulated by insulin and glucose in human adipose tissue, Eur J Endocrinol, 155, 461, 10.1530/eje.1.02229

Kershaw, 2006, Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin, Diabetes, 55, 148, 10.2337/diabetes.55.01.06.db05-0982

Jenkins, 2004, Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities, J Biol Chem, 279, 48968, 10.1074/jbc.M407841200

Johansson, 2009, Genetic variance in the adiponutrin gene family and childhood obesity, PLoS One, 4, e5327, 10.1371/journal.pone.0005327

Johansson, 2008, Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity, Eur J Endocrinol, 159, 577, 10.1530/EJE-08-0426

Benjamini, 2001, The control of the false discovery rate in multiple testing under dependency, Ann Stat, 29, 1165, 10.1214/aos/1013699998